EUVIMEDEUVIMED entdecken
Crossref

PF-08098488, A Novel CEACAM5-Targeting MMAE ADC with Optimized Engineered-Cysteine Sites Designed to Enhance Therapeutic Index, Demonstrates Potent Antitumor Activity in Preclinical Models

A. Kulukian, N. Bindman, A. Nesterova, A. Arakaki, D. Olson, S. Anderson, J. Mitchell, E. Trueblood, F. Magunda, M. Murray, K. Green, S. Wo und 7 weitere

European Journal of Cancer · 2026-11 · 248 · 117474

DOI: 10.1016/j.ejca.2026.117474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von A. Kulukian und 18 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kulukian, A., Bindman, N., Nesterova, A., Arakaki, A., Olson, D., Anderson, S., Mitchell, J., Trueblood, E., Magunda, F., Murray, M., Green, K., Wo, S., Alizadeh, K., Minussi, D. C., Zafra, C. D., Frantz, C., Jensen-Pergakes, K., Lyon, R., & Sandall, S. (2026). PF-08098488, A Novel CEACAM5-Targeting MMAE ADC with Optimized Engineered-Cysteine Sites Designed to Enhance Therapeutic Index, Demonstrates Potent Antitumor Activity in Preclinical Models. European Journal of Cancer, 248, 117474. https://doi.org/10.1016/j.ejca.2026.117474

Vancouver

Kulukian A, Bindman N, Nesterova A, Arakaki A, Olson D, Anderson S, et al. PF-08098488, A Novel CEACAM5-Targeting MMAE ADC with Optimized Engineered-Cysteine Sites Designed to Enhance Therapeutic Index, Demonstrates Potent Antitumor Activity in Preclinical Models. European Journal of Cancer. 2026;248:117474. doi:10.1016/j.ejca.2026.117474

BibTeX
@article{Kulukian2026,
  author = {Kulukian, A. and Bindman, N. and Nesterova, A. and Arakaki, A. and Olson, D. and Anderson, S. and Mitchell, J. and Trueblood, E. and Magunda, F. and Murray, M. and Green, K. and Wo, S. and Alizadeh, K. and Minussi, D. Conterno and Zafra, C. De and Frantz, C. and Jensen-Pergakes, K. and Lyon, R. and Sandall, S.},
  title = {PF-08098488, A Novel CEACAM5-Targeting MMAE ADC with Optimized Engineered-Cysteine Sites Designed to Enhance Therapeutic Index, Demonstrates Potent Antitumor Activity in Preclinical Models},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {117474},
  doi = {10.1016/j.ejca.2026.117474}
}
Kostenlos starten →